Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Abasolo

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Rheumatology (Oxford, England)|January 29, 2020
Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA RegistryCristina Vadillo, Maria Asuncion Nieto, Fredeswinda Romero-Bueno, et al.
Annals of the Rheumatic Diseases|December 23, 2020
Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Aydin <i>et al</i>Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, et al.
Annals of the Rheumatic Diseases|October 31, 2020
Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Schulze-Koops <i>et al</i>Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, et al.
Rheumatology (Oxford, England)|May 25, 2020
Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry: replyCristina Vadillo, Maria Asuncion Nieto, Fredeswinda Romero-Bueno, et al.
Pediatric Rheumatology Online Journal|April 24, 2025
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysisDaniel Clemente, Leticia Leon, Juan Carlos Nieto-Gonzalez, et al.
Rheumatology International|July 28, 2010
Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activityLuis Rodríguez-Rodríguez, José Ramón Lamas, Jezabel Varadé, et al.
Therapeutic Advances in Musculoskeletal Disease|May 5, 2022
Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center studyDalifer Freites Nuñez, Leticia Leon, Alfredo Madrid Garcia, et al.
BMC Pulmonary Medicine|July 1, 2021
Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patternsMaria A Nieto, Maria J Rodriguez-Nieto, Olga Sanchez-Pernaute, et al.
Scientific Reports|December 13, 2023
Harnessing ChatGPT and GPT-4 for evaluating the rheumatology questions of the Spanish access exam to specialized medical trainingAlfredo Madrid-García, Zulema Rosales-Rosado, Dalifer Freites-Nuñez, et al.
Respiratory Research|January 18, 2023
Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registryMaria Asuncion Nieto, Olga Sanchez-Pernaute, Cristina Vadillo, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|January 29, 2020
Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA RegistryCristina Vadillo, Maria Asuncion Nieto, Fredeswinda Romero-Bueno, et al.
Annals of the Rheumatic Diseases|December 23, 2020
Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Aydin <i>et al</i>Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, et al.
Annals of the Rheumatic Diseases|October 31, 2020
Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Schulze-Koops <i>et al</i>Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, et al.
Rheumatology (Oxford, England)|May 25, 2020
Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry: replyCristina Vadillo, Maria Asuncion Nieto, Fredeswinda Romero-Bueno, et al.
Pediatric Rheumatology Online Journal|April 24, 2025
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysisDaniel Clemente, Leticia Leon, Juan Carlos Nieto-Gonzalez, et al.
Rheumatology International|July 28, 2010
Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activityLuis Rodríguez-Rodríguez, José Ramón Lamas, Jezabel Varadé, et al.
Therapeutic Advances in Musculoskeletal Disease|May 5, 2022
Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center studyDalifer Freites Nuñez, Leticia Leon, Alfredo Madrid Garcia, et al.
BMC Pulmonary Medicine|July 1, 2021
Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patternsMaria A Nieto, Maria J Rodriguez-Nieto, Olga Sanchez-Pernaute, et al.
Scientific Reports|December 13, 2023
Harnessing ChatGPT and GPT-4 for evaluating the rheumatology questions of the Spanish access exam to specialized medical trainingAlfredo Madrid-García, Zulema Rosales-Rosado, Dalifer Freites-Nuñez, et al.
Respiratory Research|January 18, 2023
Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registryMaria Asuncion Nieto, Olga Sanchez-Pernaute, Cristina Vadillo, et al.
Pageof 8